Improving Outcomes in Children With High-Risk Neuroblastoma: The Role of Randomized Trials
- PMID: 34152837
- PMCID: PMC8330963
- DOI: 10.1200/JCO.21.01066
Improving Outcomes in Children With High-Risk Neuroblastoma: The Role of Randomized Trials
Conflict of interest statement
Comment on
-
Randomized Trial of Two Induction Therapy Regimens for High-Risk Neuroblastoma: HR-NBL1.5 International Society of Pediatric Oncology European Neuroblastoma Group Study.J Clin Oncol. 2021 Aug 10;39(23):2552-2563. doi: 10.1200/JCO.20.03144. Epub 2021 Jun 21. J Clin Oncol. 2021. PMID: 34152804 Clinical Trial.
References
-
- Matthay KK, Maris JM, Schleiermacher G, et al. Neuroblastoma. Nat Rev Dis Primers. 2016;2:16078. - PubMed
-
- Garaventa A, Poetschger U, Valteau-Couanet D, et al. Randomized trial of two induction therapy regimens for high-risk neuroblastoma HR-NBL1.5 International Society of Pediatric Oncology European Neuroblastoma Group study J Clin Oncol 392552–25632021 - PubMed
-
- Pearson AD, Pinkerton CR, Lewis IJ, et al. High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: A randomised trial Lancet Oncol 9247–2562008 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
